Ergomed’s interim results highlight continued progression and robust growth in its services business. The five current co- development deals offer potentially very attractive returns with clinical data from 4 due between now and the end of 2016, providing upside potential to our 290p TP. We continue to see organic growth opportunities in the group’s service offering and co-development business as well as potential acquisitive growth to accelerate service expansion and enhance geographical presen ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Interim results in line with expectations
- Published:
29 Sep 2015 -
Author:
Sheena Berry -
Pages:
3
Ergomed’s interim results highlight continued progression and robust growth in its services business. The five current co- development deals offer potentially very attractive returns with clinical data from 4 due between now and the end of 2016, providing upside potential to our 290p TP. We continue to see organic growth opportunities in the group’s service offering and co-development business as well as potential acquisitive growth to accelerate service expansion and enhance geographical presen ....